Sodium orthovanadate overcomes sorafenib resistance of hepatocellular carcinoma cells by inhibiting Na+/K+-ATPase activity and hypoxia-inducible pathways
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Sodium orthovanadate overcomes sorafenib resistance of hepatocellular carcinoma cells by inhibiting Na+/K+-ATPase activity and hypoxia-inducible pathways
Authors
Keywords
-
Journal
Scientific Reports
Volume 8, Issue 1, Pages -
Publisher
Springer Nature
Online
2018-06-20
DOI
10.1038/s41598-018-28010-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Dual inhibition of Akt and c-Met as a second-line therapy following acquired resistance to sorafenib in hepatocellular carcinoma cells
- (2017) Peng Han et al. Molecular Oncology
- Na/K Pump and Beyond: Na/K-ATPase as a Modulator of Apoptosis and Autophagy
- (2017) Cassiano Felippe Gonçalves-de-Albuquerque et al. MOLECULES
- Development of Inhibitors Targeting Hypoxia-Inducible Factor 1 and 2 for Cancer Therapy
- (2017) Tianchi Yu et al. YONSEI MEDICAL JOURNAL
- Selective cytotoxicity of vanadium complexes on human pancreatic ductal adenocarcinoma cell line by inducing necroptosis, apoptosis and mitotic catastrophe process
- (2017) Szymon Kowalski et al. Oncotarget
- The Structure and Function of the Na,K-ATPase Isoforms in Health and Disease
- (2017) Michael V. Clausen et al. Frontiers in Physiology
- Personalized therapy for hepatocellular carcinoma: Where are we now?
- (2016) Stephen L. Chan et al. CANCER TREATMENT REVIEWS
- The Function of V-ATPases in Cancer
- (2016) Laura Stransky et al. PHYSIOLOGICAL REVIEWS
- Targeting Na+/K+-translocating adenosine triphosphatase in cancer treatment
- (2015) Cameron T. Durlacher et al. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
- Novel drugs in clinical development for hepatocellular carcinoma
- (2015) Oliver Waidmann et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Cytotoxicity of cardiotonic steroids in sensitive and multidrug-resistant leukemia cells and the link with Na+/K+-ATPase
- (2015) Maen Zeino et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Inhibition of Na+/K+-ATPase induces hybrid cell death and enhanced sensitivity to chemotherapy in human glioblastoma cells
- (2014) Dongdong Chen et al. BMC CANCER
- 2-Methoxyestradiol synergizes with sorafenib to suppress hepatocellular carcinoma by simultaneously dysregulating hypoxia-inducible factor-1 and -2
- (2014) Li Ma et al. CANCER LETTERS
- Sodium orthovanadate inhibits growth of human hepatocellular carcinoma cells in vitro and in an orthotopic model in vivo
- (2014) Yaohua Wu et al. CANCER LETTERS
- Upregulation of HIF-2α induced by sorafenib contributes to the resistance by activating the TGF-α/EGFR pathway in hepatocellular carcinoma cells
- (2014) Dali Zhao et al. CELLULAR SIGNALLING
- Lactate Dehydrogenase A is a potential prognostic marker in clear cell renal cell carcinoma
- (2014) Hala Girgis et al. Molecular Cancer
- Inhibition of Akt Reverses the Acquired Resistance to Sorafenib by Switching Protective Autophagy to Autophagic Cell Death in Hepatocellular Carcinoma
- (2014) B. Zhai et al. MOLECULAR CANCER THERAPEUTICS
- Hepatocellular carcinoma and sorafenib: too many resistance mechanisms?
- (2013) Carmen Berasain GUT
- V-ATPase inhibition overcomes trastuzumab resistance in breast cancer
- (2013) Karin von Schwarzenberg et al. Molecular Oncology
- Cardiotonic Steroids-Mediated Na+/K+-ATPase Targeting Could Circumvent Various Chemoresistance Pathways
- (2013) Tatjana Mijatovic et al. PLANTA MEDICA
- Targeting cellular metabolism to improve cancer therapeutics
- (2013) Y Zhao et al. Cell Death & Disease
- Human erythrocytes and neuroblastoma cells are in vitro affected by sodium orthovanadate
- (2012) M. Suwalsky et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
- Resistance and Escape From Antiangiogenesis Therapy: Clinical Implications and Future Strategies
- (2012) Justin N. Bottsford-Miller et al. JOURNAL OF CLINICAL ONCOLOGY
- Cytotoxic effect of menadione and sodium orthovanadate in combination on human glioma cells
- (2011) Zahid M. Delwar et al. INVESTIGATIONAL NEW DRUGS
- Differential Hypoxic Regulation of Hypoxia-Inducible Factors 1 and 2
- (2011) Q. Lin et al. MOLECULAR CANCER RESEARCH
- Cell metabolism: An essential link between cell growth and apoptosis
- (2010) Emily F. Mason et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Roles of hypoxia-inducible factor-1α (HIF-1α) versus HIF-2α in the survival of hepatocellular tumor spheroids
- (2010) Heidi Menrad et al. HEPATOLOGY
- Inhibition of the Sodium Potassium Adenosine Triphosphatase Pump Sensitizes Cancer Cells to Anoikis and Prevents Distant Tumor Formation
- (2009) C. D. Simpson et al. CANCER RESEARCH
- Decavanadate (V10O286-) and oxovanadates: Oxometalates with many biological activities
- (2008) Manuel Aureliano et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
- (2008) Ann-Lii Cheng et al. LANCET ONCOLOGY
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
- Digoxin and other cardiac glycosides inhibit HIF-1 synthesis and block tumor growth
- (2008) H. Zhang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now